Proxy Votes Now

Home › Funds › GMO › GMO U.S. Small Cap Value Fund

GMO U.S. Small Cap Value Fund (GCAVX) proxy voting record 2025-2026

Fund family: GMO · Filed by GMO TRUST (CIK 772129) · SEC series S000065871

Ticker: GCAVX (C000212810)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,510 with, 26 against, 0 abstentions (not counted as with management). Shareholder proposals: 11 FOR, 6 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with GMO as a whole

The same two figures as GMO’s manager page (51,210 ballot items across 26 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsGMOItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)92.6%2,44891.3%40,970
Backed environmental and social shareholder proposals at US companiesn/a210.3%369

Where this fund voted differently from most GMO funds

Each ballot item this fund voted is set against the votes of the other GMO funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most GMO funds on all 262 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.5% of this fund’s 2,536 such votes could be given a sector; the other 89 (3.5%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary758121.6%
Finance59110.2%
Industrials27331.1%
Technology19821.0%
Real Estate16600.0%
Health Care15831.9%
Energy14100.0%
Consumer Staples6311.6%
Basic Materials3400.0%
Utilities2800.0%
Miscellaneous1900.0%
Telecommunications1800.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,79210
Say-on-Pay2800
Audit-related2570
Compensation1000
Corporate Governance7012
Extraordinary Transactions321
Capital Structure161
Shareholder Rights and Defenses80
Environment or Climate22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Sandisk CorporationNovember 18, 2025$7M100
Lincoln National CorporationMay 28, 2026$1M131
Skyworks Solutions, Inc.May 13, 2026$987,744171
Jackson Financial Inc.May 21, 2026$932,719110
Enova International, Inc.May 13, 2026$932,312130
BorgWarner Inc.April 29, 2026$863,614121
Axcelis Technologies, Inc.May 5, 2026$862,817100
Macy's, Inc.May 15, 2026$838,930130

Notable votes against management

MeetingCompanyProposalFundMgmt
May 28, 2026Lincoln National CorporationShareholder proposal to amend our governing documents to provide for an independent chairman of the board. Shareholder proposalForAgainst
May 13, 2026Skyworks Solutions, Inc.To approve a stockholder proposal regarding greenhouse gas emission reduction efforts report. Shareholder proposalForAgainst
April 29, 2026BorgWarner Inc.Vote on stockholder proposal regarding action by written consent. Shareholder proposalAgainstFor
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
May 5, 2026Oshkosh CorporationTo vote on a shareholder proposal on the subject of directors who fail to obtain a majority vote. Shareholder proposalAgainstFor
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 7, 2026Eastman Chemical CompanyAdvisory Vote on Stockholder Proposal Regarding Lowering the Threshold for Calling Special Shareholder Meetings to 10% Shareholder proposalForAgainst
May 21, 2026Meritage Homes CorporationShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalForAgainst
April 22, 2026Levi Strauss & Co.Shareholder proposal, if properly presented at the meeting, requesting Bylaw Amendment related to Sustainability ROI Report by Audit Committee. Shareholder proposalAgainstFor
May 20, 2026The Wendy's CompanyStockholder proposal regarding a restriction on "blank-check" preferred stock, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
April 22, 2026Dana IncorporatedShareholder proposal to require an independent Board Chairman. Shareholder proposalForAgainst
April 30, 2026Ingles Markets, IncorporatedTo elect two directors to serve until the Company's 2027 annual meeting of shareholders and until their successors are duly elected and qualified: SUMMER ROAD NOMINEE: Rory A. Held Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (3 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

2,557 ballot items at 279 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, GMO U.S. Small Cap Value Fund (GCAVX) voted at 279 shareholder meetings of 269 companies, on 2,557 ballot items in all. Where management made a recommendation, the fund followed it on 99.0% of the items and voted against it 26 times. Its most frequent area of disagreement was corporate governance (12 of its votes against management). It voted on 22 shareholder proposals. It voted FOR the board's own proposals more often than GMO's funds as a whole (92.6% against 91.3%). It voted the same way as most GMO funds on every item where a comparison was possible. 3 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of GMO’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.